METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER
Clinical trials for METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo offers hope for Hard-to-Treat GI cancers
Disease control OngoingThis study tests a combination of two drugs (vorbipiprant and balstilimab) in people with advanced colorectal or other gastrointestinal cancers that have not responded to prior treatments. The goal is to see if the combination is safe and can shrink tumors or stop them from growi…
Matched conditions: METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Rottapharm Biotech • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for Hard-to-Treat colorectal cancer: combination therapy trial underway
Disease control OngoingThis study tests whether adding new cancer drugs to standard chemotherapy can better control metastatic colorectal cancer that is microsatellite-stable. About 61 adults with this advanced cancer will receive different drug combinations. The main goals are to check safety and see …
Matched conditions: METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: MedImmune LLC • Aim: Disease control
Last updated May 14, 2026 12:05 UTC